Targeting mitochondrial Ca 2+ uptake for the treatment of amyotrophic lateral sclerosis
The Journal of Physiology · 2024
DOI: 10.1113/jp284143 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Physiology, 2024. Verfasst von Renjia Zhong und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Physiology and Kinesiology, College of Health and Human Performance, University of Florida, Gainesville, FL, USA. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Neurodegenerative Diseases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 311 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS.
Abstract (Originalsprache)
Amyotrophic lateral sclerosis (ALS) is a rare adult‐onset neurodegenerative disease characterized by progressive motor neuron (MN) loss, muscle denervation and paralysis. Over the past several decades, researchers have made tremendous efforts to understand the pathogenic mechanisms underpinning ALS, with much yet to be resolved. ALS is described as a non‐cell autonomous condition with pathology detected in both MNs and non‐neuronal cells, such as glial cells and skeletal muscle. Studies in ALS patient and animal models reveal ubiquitous abnormalities in mitochondrial structure and function, and disturbance of intracellular calcium homeostasis in various tissue types, suggesting a pivotal role of aberrant mitochondrial calcium uptake and dysfunctional calcium signalling cascades in ALS pathogenesis. Calcium signalling and mitochondrial dysfunction are intricately related to the manifestation of cell death contributing to MN loss and skeletal muscle dysfunction. In this review, we discuss the potential contribution of intracellular calcium signalling, particularly mitochondrial calcium uptake, in ALS pathogenesis. Functional consequences of excessive mitochondrial calcium uptake and possible therapeutic strategies targeting mitochondrial calcium uptake or the mitochondrial calcium uniporter, the main channel mediating mitochondrial calcium influx, are also discussed. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Applied Physiology and Kinesiology, College of Health and Human Performance, University of Florida, Gainesville, FL, USA.
- Department of Emergency Medicine, the First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China.
- Myology Institute, University of Florida, Gainesville, FL, USA.
ORCID-Profile: Lan Wei-LaPierre
Förderung
- NINDS NIH HHS
Zitieren
APA
Zhong, R., Rua, M. T., & Wei-LaPierre, L. (2024). Targeting mitochondrial Ca 2+ uptake for the treatment of amyotrophic lateral sclerosis. The Journal of Physiology. https://doi.org/10.1113/jp284143
Vancouver
Zhong R, Rua MT, Wei-LaPierre L. Targeting mitochondrial Ca 2+ uptake for the treatment of amyotrophic lateral sclerosis. The Journal of Physiology. 2024. doi:10.1113/jp284143
BibTeX
@article{Zhong2024,
author = {Zhong, Renjia and Rua, Michael T and Wei-LaPierre, Lan},
title = {Targeting mitochondrial Ca 2+ uptake for the treatment of amyotrophic lateral sclerosis},
journal = {The Journal of Physiology},
year = {2024},
doi = {10.1113/jp284143}
}
EUVIMED